SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-057025
Filing Date
2023-07-14
Accepted
2023-07-14 13:29:14
Documents
58
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0323_bespoke.htm   iXBRL 10-Q 471130
2 CERTIFICATION f10q0323ex31-1_bespoke.htm EX-31.1 10609
3 CERTIFICATION f10q0323ex32-1_bespoke.htm EX-32.1 3948
  Complete submission text file 0001213900-23-057025.txt   3788977

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bspk-20230331.xsd EX-101.SCH 48817
5 XBRL CALCULATION FILE bspk-20230331_cal.xml EX-101.CAL 29056
6 XBRL DEFINITION FILE bspk-20230331_def.xml EX-101.DEF 224581
7 XBRL LABEL FILE bspk-20230331_lab.xml EX-101.LAB 458095
8 XBRL PRESENTATION FILE bspk-20230331_pre.xml EX-101.PRE 237085
52 EXTRACTED XBRL INSTANCE DOCUMENT f10q0323_bespoke_htm.xml XML 282831
Mailing Address 2590 WALNUT ST. DENVER CO 80205
Business Address 2590 WALNUT ST. DENVER CO 80205 855-633-3738
Bespoke Extracts, Inc. (Filer) CIK: 0001409197 (see all company filings)

IRS No.: 204743354 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52759 | Film No.: 231088686
SIC: 2834 Pharmaceutical Preparations